-+ 0.00%
-+ 0.00%
-+ 0.00%

Kiniksa Pharmaceuticals Raises FY2025 Sales Guidance from $560.00M-$580.00M to $590.00M-$605.00M vs $698.99M Est

Benzinga·04/29/2025 11:33:41
Listen to the news
Kiniksa Pharmaceuticals (NASDAQ:KNSA) raises FY2025 sales outlook from $560.00 million-$580.00 million to $590.00 million-$605.00 million vs $698.99 million estimate.